Approved: TransEnterix stock spikes on FDA clearance
October 13, 2017 at 18:22 PM EDT
Research Triangle Park-based TransEnterix saw its stock soar more than 80 percent after hours Friday on news that it received U.S. Food and Drug Administration clearance for its Senhance surgical robot.
